# Neuphoria Therapeutics Inc.: Form 6-K, filed Nov 30, 2023

- Company: [Neuphoria Therapeutics Inc.](/companies/neup.md) (CIK 1191070)
- Form: 6-K
- Filed: 2023-11-30
- Accepted by EDGAR: Nov 30, 2023, 11:02 ET
- Period: 2023-11-30
- Accession: 0000950170-23-066890
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1191070/000095017023066890/bnox-6k-2023agm_results.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1191070/000095017023066890/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1191070/000095017023066890/bnox-6k-2023agm_results.htm

Filed Nov 30, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-066890. Last ingested by Listed: Oct 24, 2026, 15:10 ET. No prices; not investment advice.